Screener
Neurocrine Biosciences NBIX Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Neurocrine Biosciences in its filing.
Tagged under the XBRL concept us-gaap:OtherPrepaidExpenseCurrent.
The source filing: Neurocrine Biosciences’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000914475-26-000026
FAQ
- What is Neurocrine Biosciences's prepaid & other current?
- Neurocrine Biosciences (NBIX) reported prepaid & other current of $27.5M in Q1 2026.
- How has Neurocrine Biosciences's prepaid & other current changed year-over-year?
- Neurocrine Biosciences's prepaid & other current decreased by 76.9% year-over-year, from $119.3M to $27.5M.
- What is the long-term trend for Neurocrine Biosciences's prepaid & other current?
- Over 5 years (2020 to 2025), Neurocrine Biosciences's prepaid & other current has grown at a -6.9% compound annual growth rate (CAGR), from $30.1M to $21.1M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Neurocrine Biosciences's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude